Setting new standards in information exchange for the pharmaceutical and biotech industry

News

Conference Forum News


  • February 6, 2017

  • Clinical Trials as a Care Option event will be launched in April 2017

    The Conference Forum is pleased to announce the launch of Clinical Trials as a Care Option (CRAACO), which will take place on April 4, 2017 in Boston, MA. This half-day event is designed to help bring clinical research closer to patients and patients closer to clinical trials. “Transforming clinical trials into a care option is […]

    Read More »

  • February 1, 2017

  • Tackling rare disease with the voice of patients

    Proponents of big data methodologies are excited about their potential applications in rare disease research, including in: drug discovery; the discovery of disease-related genes, genetic mutations and biomarkers; matchmaking of rare disease cases to help diagnose patients; and drug repurposing. But while great insights can be gleaned from huge datasets, equally valuable and complementary intelligence […]

    Read More »

  • January 20, 2017

  • 2nd annual Clinical Trial Collaborations Launches

    2017 Clinical Trial Collaborations Conference: Here’s What You Need to Know Want to find out how to foster collaboration to deliver improved clinical trial outcomes? Check out the 2nd annual Clinical Trial Collaborations (CTC) conference in Boston on April 3 and 4. Led by Co-Chair Katherine Vandebelt, Global Head of Clinical Innovation at Eli Lilly, […]

    Read More »

  • January 9, 2017

  • Announcing Immuno-Oncology KOL Panel at the JPM Health Week in San Francisco

    We are pleased to announce that the IO360 team at the Conference Forum together with BioPharm Insight are co-presenting a panel discussion on Immuno-Oncology: Filtering the Hype for the Next Wave of Targets along side the JP Morgan HealthCare conference. The panel discussion will take place January 9, 2017 at the Chandran Art Gallery in San Francisco. […]

    Read More »

  • December 17, 2016

  • Conference Forum Team Celebrates 2016 and a New Baby!

    The Conference Forum team set out on a holiday lunch celebration afternoon at the Tavern on the Green. Originally designed by Calvert Vaux and built in 1870 to house the Central Park sheep, Tavern on the Green is a New York City iconic restaurant located on the west side of Central Park. We had much […]

    Read More »

  • December 14, 2016

  • Congrats to US Rep Diana DeGette for Driving 21st Century Cures into Law!

    Congratulations to US Rep Diana DeGette for leading the charge on 21st Century Cures, which President Obama signed into law today. Members of the DPharm 2014 faculty and I met with Diana to provide industry feedback. The bill contains provisions to fund a handful of high-profile NIH initiatives, creates an approval pathway for antibiotics targeting […]

    Read More »

  • December 8, 2016

  • What to Expect at DPharm Europe 2017

    The Conference Forum has announced the 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event on Feb. 8 and 9, 2017 in London. This year’s conference promises to challenge conventional thinking and inspire new ideas for the advancement of clinical research. DPharm Europe features: Clinical Trial Discussions: – Disruptive ideas that are reshaping […]

    Read More »

  • December 7, 2016

  • Patients as Partners Opens in Europe this February in London

    At the request of our European attendees at the Patients as Partners US event to bring the conference to Europe, we are delighted to announce we are doing just that on February 6-7, 2017 in London. Patients as Partners EU is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program […]

    Read More »

  • December 2, 2016

  • Immuno-Oncology 360° in 60 seconds

    The Immuno-oncology 360° program provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated. IO360° will take place at The Roosevelt Hotel in New York City, February 1 – 3, 2017. For more […]

    Read More »

  • December 1, 2016

  • IO360 Speaking Faculty Launch Collaboration on Cancer Neoantigens

    Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) recently announced a major collaboration focused on cancer neoantigens to accelerate the discovery of personalized cancer immunotherapies. “We’re proud to join the Parker Institute in this collaboration, which demonstrates the vital role that nonprofits can play in bringing together stakeholders from across sectors to […]

    Read More »

  • November 18, 2016

  • EMA Begins Providing Public Access to Clinical Reports

    Beginning in October 2016, the European Medicines Agency (EMA) has made a decision to support transparency in clinical trials by giving open access to clinical reports for new medicines for human use authorized in the European Union (EU). EMA is the first regulatory authority worldwide to provide such broad access to clinical data. “Transparency on clinical data is a […]

    Read More »

  • November 17, 2016

  • Lilly is Making It Easier For Physicians To Become Investigators

    We are so proud of Conference Forum speaker Katherine Vandebelt, Head of Clinical Innovation at Eli Lilly for her vision and leadership in making it easier for physicians to become investigators. She understands the burden on the physician in navigating the clinical research process and is leading efforts to reduce this burden. Katherine spoke to […]

    Read More »

  • November 16, 2016

  • Patients as Partners Speakers Collaborate on Inaugural Patient Engagement White Paper

    Patients as Partners EU and US speakers including Marc Boutin, National Health Council, Tony Hoos, Amgen EU, Andrew Garvey, GSK, Jan Geissler, EUPATI, Veronica Todaro, Parkinson’s Disease Foundation, Roslyn Schneider, Pfizer and Sarah Krüg, Cancer 101, collaborated on an inaugural white paper focusing on culture and process change as a priority for patient engagement. Patient Focused Medicine’s […]

    Read More »

  • October 28, 2016

  • Recap of PODD 2016

    PODD 2016 Day One: October 27 Recap The sixth annual Partnership Opportunities in Drug Delivery (PODD) conference is officially underway at Boston’s Fairmont Copley Plaza. If you missed Day One of the conference, we can’t replicate the partnering and networking, but we can provide you with a closer look at five key topics that were […]

    Read More »

  • October 27, 2016

  • MIT’s Robert Langer Receives Award at PODD 2016

    Partnership Opportunities in Drug Delivery (PODD) Chair Dr Barbara Lueckel kicked off this year’s PODD conference by recognizing one of the event’s long-time contributors – Robert Langer. Langer, David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT), received an award prior to his PODD 2016 keynote address in recognition of his contributions […]

    Read More »

  • September 28, 2016

  • PODD Speaker, Insitu Biologics Publishes White Paper on AnestaGel

    Authors: William Taylor, Daniel P. Sipple, D.O., F.A.B.P.M.R., D.A.B.P.M., Stefano M. Sinicropi, M.D., F.A.A.O.S. author white paper on the feasibility and duration of AnestaGel-P, a novel hydrogel-based drug delivery system to provide sustained analgesia was evaluated in a post-operative incisional pain rat model when compared to a positive control, Exparel®. Click here for the entire white […]

    Read More »

  • September 21, 2016

  • Florence Healthcare Wins DPharm Idol 2016

    Congratulations to Florence Healthcare, this year’s DPharm Idol winner! Florence was founded by Andres Garcia (CTO), Mike Kassin, MD (CMO), and Ryan Jones (CEO), — who previously held positions at Microsoft SharePoint, Pubget and BCG. The company name echoes Florence Nightengale, the mother of modern nursing, and embodies the ideals of empathy, reliability and consistency. […]

    Read More »

  • September 21, 2016

  • DPharm 2016 Day Two Recap

    September 21st, Boston, the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference has drawn to a close. DPharm day two featured engaging discussions on a variety of topics, including: DPharm Idol Florence Healthcare, an Atlanta-based provider of a software-as-a-service (SaaS) clinical trial document management platform, won this year’s DPharm Idol competition. The Florence […]

    Read More »

  • September 20, 2016

  • DPharm 2016 Day One Recap

    The 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference is officially underway this week in Boston. Did you miss out on DPharm day one? Here’s a look at five key topics that were discussed during DPharm’s day one sessions. Embracing Limitations Pointillist artist Phil Hansen delivered DPharm’s patient address and described how he […]

    Read More »

  • September 4, 2016

  • Keynote Fireside Chat: How Juno Therapeutics Went from 30 to 300

    Mark Frohlich, EVP of Portfolio Strategy, Juno Therapeutics sits down with investor, Mark Simon, Torreya Partners to talk about the progress Juno made as a small biotech company comprised of 30 people, now over 300, and the challenges they faced along the way including: – Decision making with 30 people versus 300 – Leveraging outside […]

    Read More »

  • September 3, 2016

  • CMO/R&D Summit Announce Keynote Fireside Chat with Dr Diego Miralles

    The CMO/R&D Summit is delighted to announce that the former global head of innovation at Johnson & Johnson, Dr Diego Miralles, now President at Adaptive Therapeutics will discuss his leadership and experience in building therapeutic programs. Interviewed by Dr Lee Allen, CMO of Argos Therapeutics, the fireside chat with Dr Miralles will discuss identifying the […]

    Read More »

  • August 23, 2016

  • Pfizer’s “Blue Sky” Team Featured on PharmaTalkRadio

    Members of Pfizer’s “Blue Sky” team join DPharm’s Director, Valerie Bowling and Clinical Leader’s Chief Editor, Ed Miseta on PharmaTalkRadio to discuss the work they are doing to transform clinical research in Parkinson’s disease and patient-centric innovation. Together they discuss the vision, goals and journey in taking a new approach to advancing drug development. More […]

    Read More »

  • August 18, 2016

  • PharmaTalkRadio: DPharm Team Discuss the 2016 Highlights

    Members of the DPharm team engage in an informal conversation to highlight what’s happening in innovation and the latest thinking to disrupt clinical trials at the 6th annual event. Also discussed is a brief history of how this conference dedicated to applying disruptive thinking to clinical trials came to be. This conversation is well worth […]

    Read More »

  • August 1, 2016

  • NYT’s Cover Story on Harnessing the Immune System to Fight Cancer

    This past weekend, the New York Times cover story featured several patients who have participated in cancer immunotherapy clinical trials and profiled a number of the IO360 speakers. The article gives hope for the future of IO. Immuno-Oncology 360° speaker Dr Jedd Wolchok of Memorial Sloan Kettering Cancer Center commented that “this [immunotherapy] is a […]

    Read More »

  • July 28, 2016

  • Conference Forum Journeys to Governors Island for Summer Outing

    Approximately 800 yards from the southern tip of Manhattan, Governors Island is a national historic landmark district requiring a short ferry ride to get on the island. For their annual summer outing, the Conference Forum team headed on over to the island on July 27th for a festive picnic.   Organized by The Perfect Picnic […]

    Read More »

  • July 6, 2016

  • Dpharm Europe Speaker Alexander Masters on Crowd Funding Cancer Cures

    We are delighted to highlight the latest piece printed in the London Telegraph by DPharm Europe speaker, Alexander Masters on the latest in a new financial paradigm to help fight cancer. From the Telegraph: The first person in the world to receive the only crowd-funded cancer drug in history will be Jan Smørlung, a village […]

    Read More »

  • June 30, 2016

  • PODD: Partnership Opportunities in Drug Delivery 6th Annual Event Announced

    Tthe 6th Annual Partnership Opportunities in Drug Delivery (PODD) conference will take place on October 27-28, 2016 at the Fairmont Copley Plaza in Boston, MA. This strategic-level event covers the latest drug delivery technology developments and fosters a network of more than 300 key decision makers in the drug delivery, pharmaceutical and biotechnology industries. PODD […]

    Read More »

  • June 30, 2016

  • 6th Annual DPharm Agenda Published

    We are excited to announce the first draft of the agenda for the 6th Annual DPharm: Disruptive Innovations to Advance Clinical Trials is published. DPharm 2016 opens with artist Phil Hansen, who provides his perspective as a patient on turning a nearly tragic disability into an overflowing amount of creativity. To demonstrate innovative ways to transform patient […]

    Read More »

  • May 31, 2016

  • Patients as Partners Attendee Julie Walters on Putting the Patient First

    Julie Walters discusses the Patients as Partners Event. Originally published on LinkedIn. Putting the patient first: Time to stop talking & start doing It’s rare that you find yourself in the right place, at the right time, with the right people. But it happened last month. I was part of a small but determined group […]

    Read More »

  • May 26, 2016

  • Mobile in Clinical Trials Agenda Announced!

    The 3rd Annual Mobile in Clinical Trials program agenda is published! The 2016 event takes place September 19th at the Fairmont Copley Plaza Hotel Boston. The theme for 2016 is implementation, scale up and making mobile a reality finally in drug development. We are delighted to welcome back Pfizer’s Dr Dan Karlin, Human Biology Lead, […]

    Read More »

  • May 13, 2016

  • PharmaTalk Radio Looks at Puerto Rico as an Option for Clinical Trials

    PharmaTalk Radio producer, Valerie Bowling welcomed Dr Myrto Lee, Director, PwC’s Strategy&, UK and Dr Kosmas Kretsos, Executive Director of the Puerto Rico Consortium for Clinical Investigation to learn about key initiatives and outcomes so far to make running clinical trials more attractive in Puerto Rico. They discussed  the quality, capacity and efficiency of running […]

    Read More »

  • May 5, 2016

  • Featured Business Panel at Rational Combinations 360°

    Rational Combinations 360°, an IO conference dedicated to combination immunotherapy approaches is delighted to confirm a buyside investment panel moderated by Mark Simon, MBA, Partner, Torreya Partners. This talk will address perspectives on investing in companies developing IO combination products. The panel will answer the following questions: Would you make an investment in an IO […]

    Read More »

  • April 29, 2016

  • 10 Conference Forum Speakers make Medicine Makers 2016 Power List

    Congratulations to the Conference Forum speakers featured in The Medicine Makers 2016 Power List. According to Medicine Makers, the list contains the “Top 100 most influential people in the world of drug development and manufacture.”   Congratulations to: DPharm: Disruptive Innovations to Advance Clinical Trial Speakers Ibraheem Mahmood, DrugDev Tomasz Sablinski, Transparency Life Sciences Dalvir […]

    Read More »

  • April 25, 2016

  • PODD Speaker Dr. Tugrul Karali from PharmaCircle on whether Injectables are the new Oral

    Published in the April issue of Contract Pharma, Dr. Karali’s article, “Injectables – The New Oral?,” takes inspiration from his presentation at the PODD (Partnership Opportunities in Drug Delivery) October 2015 Conference. Supported by PharmaCircle data, the article suggests that injectables have become a delivery route of significant interest for Pharma and Specialty Pharma companies. […]

    Read More »

  • April 19, 2016

  • Conference Forum Proud to Support Dance Against Cancer

    The Conference Forum is proud to support Dance Against Cancer (DAC). The 6th annual performance took place on April 25th at the AXA Equitable Theater in NYC. Dance Against Cancer brings together top dance companies and the Broadway community for an evening of beautiful performances and world premiere solos. This year’s event featured performances from […]

    Read More »

  • April 12, 2016

  • Hear Agios CEO, Dr David Schenkein’s Keynote from the 2015 CMO East Summit

    At the 2015 Chief Medical Officer Summit in Boston, David Schenkein, MD, CEO, Agios provided a warm and personal keynote sharing his journey as a Physician CEO. In this recording of the session, gain an insight into Dr. David Schenkein’s journey from physician to CEO of a biopharmaceutical company leading the way in the field […]

    Read More »

  • April 11, 2016

  • Congratulations to Conference Forum speaker, Dr Jules Mitchel

    Congratulations to Conference Forum speaker, Dr Jules Mitchel, President of Target Health for his company’s recognition by the International World Trade Week in NYC, where he will receive an award for cost effective streamlining of the clinical research process on May 16, 2016. This award is from New York City, where Jules works and lives […]

    Read More »

  • April 4, 2016

  • PharmaTalkRadio Covers A New Economic Solution to Drive Cures to Patients

    PharmaTalkRadio features a radio discussion on a new model to repurpose drugs in unsolved diseases. Generic drugs can be repurposed to create effective treatments in unsolved diseases. However, there is no economic incentive for industry to pay for a clinical validation and regulatory approval process for most generic drug repurposing because it will not achieve […]

    Read More »

  • March 30, 2016

  • Carl June, MD, Immuno-Oncology Pioneer Speaks with Valerie Bowling at IO360

    Conference Forum Executive Director, Valerie Bowling sat down with Immuno-Oncology pioneer, Dr Carl June, University of Pennsylvania at the IO360° conference. They covered a range of topics from how Dr June got involved in immuno-oncology when most scientists and oncologists did not focus on the space to current challenges and progress. Watch the interview below. […]

    Read More »

  • March 25, 2016

  • May 4th, the Conference Forum will be at d.health Summit

    Second Annual d.health Summit 2016 Wednesday, May 4 at the New York Academy of Sciences Audience: Healthcare leaders, entrepreneurs, tech firms, policymakers & financiers – learn more. Speakers & Agenda: Read 2016 speaker bios here & find a full Summit agenda here. Sponsorship: Opportunities are still available & range from $2,500 to $50k – learn […]

    Read More »

  • March 14, 2016

  • What Will Be The End Result Of Bullying Biopharma?

    By Rob Wright, Chief Editor, Life Science Leader If as adults we could invisibly walk on school playgrounds during recess, we might hear the stock response recited when encountering a bully — ‘Sticks and stones may break my bones, but words will never hurt me.” How could we be so wrong? Words most certainly hurt, […]

    Read More »

  • March 14, 2016

  • The Chief Medical Officer Summit 2016 Announces 2 New Co-Chairs

    We are delighted to announce women leadership at the 4th Annual Chief Medical Officer Summit. ShiYin Foo, MD, PhD, CMO, Cardioxyl and Catherine Wheeler, MD, CMO, SVP Clinical Development, Acetylon Pharmaceuticals are confirmed to co-chair the event on May 11-12th in Boston, MA. Drs Foo and Wheeler will provide valuable insight and leadership during the […]

    Read More »

  • March 14, 2016

  • R&D Leadership Summit Provides Ear-Opening Experience

    Guest Post by Rob Wright from Life Science Leader Life Science Leader magazine and CNBC were the only two members of the media invited to attend the 6th Annual R&D Leadership (RDL) Summit (I will explain why this is significant in a moment). Produced by the Conference Forum with support from PRA Health Sciences, the […]

    Read More »

  • January 26, 2016

  • IO360° Speaker Dr. Carl June Launches New T-Cell Company, Tmunity Therapeutics

    Congratulations to Immuno-Oncology 360° speaker Dr. Carl June, Director of the Translational Research Program at the University of Pennsylvania who recently co-founded Tmunity Therapeutics, an organization that is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. “The creation of Tmunity is the culmination of […]

    Read More »

  • January 25, 2016

  • Partnering with Patients in the Development & Lifecycle of Medicines

    Pharmatalk’s Valerie Bowling welcomes Anton (Tony) Hoos, MD, Head of Medical, Amgen Europe and Marc Boutin, JD, Chief Executive Officer, National Health Council. The topic of the show is inspired by a 2015 DIA published paper by a similar name, Partnering with Patients in the Development and Lifecycle of Medicines: A Call for Action. Dr […]

    Read More »

  • January 19, 2016

  • Singing Opera with Someone Else’s Lungs

    In September 2015, we were honored to open the 5th annual DPharm conference with Charity Sunshine Tillemann-Dick, a coloratura soprano and composer. After being diagnosed with Idiopathic Pulmonary Hypertension she received two double lung transplants. We share her story, a journey you will never forget and it reminds all of us the central reason why […]

    Read More »

  • January 13, 2016

  • A Moonshot to Cure Cancer by Vice President Joe Biden

    We are pleased to hear the announcement that Vice President Biden will lead a new national mission to “moonshot” a cure for cancer. Below is his blog posting on what this will entail. Inspiring a New Generation to Defy the Bounds of Innovation: A Moonshot to Cure Cancer. Three months ago, I called for a […]

    Read More »

  • January 11, 2016

  • Top 10 Medical Research Issues and Trends to Watch in 2016

    Conference Forum speaker and Executive Director of FasterCures, Margaret Anderson released FasterCure’s recommendations on the Top 10 Medical Research Issues and Trends to Watch in 2016. Patient engagement is listed as the number one priority on their top 10 list. They talk about the importance of patient input on R&D and how patient involvement needs […]

    Read More »

  • January 4, 2016

  • Measuring Immunotherapy’s Past Year

    2015 was another year of outperformance for cancer immunotherapy companies. As measured by the Loncar Cancer Immunotherapy Index, cancer immunotherapy stocks were up 19.2% in 2015 versus 11.4% for the Nasdaq Biotechnology Index. This is in stark contrast to the broader stock market, as the Standard and Poor’s 500 Index fell 0.7% in 2015, its […]

    Read More »

  • December 23, 2015

  • Immuno-Oncology Drug Development: Challenges & Next Steps

    PharmaTalk Radio’s Valerie Bowling welcomes Immuno-Oncology 360° Co-Chair James Gulley, MD, PhD, National Cancer Institute as he leads a discussion with fellow Co-Chair, Axel Hoos, MD, PhD, GlaxoSmithKline. Together they discuss what’s currently happening in Immuno-Oncology and its impact on how cancer is being treated. They cover the latest challenges and next steps. More specifically […]

    Read More »

  • December 21, 2015

  • CISCRP Names Patients as Partners Speaker Kyle Bryant a Medical Hero

    “There’s a chance that these drugs could be therapeutic for me, but that’s not why I participate. I participate because I want to push the science forward. There is no way to get these trials done without participants. Even if these drugs aren’t helpful for me now, it will help find something in the future.” […]

    Read More »

  • December 16, 2015

  • New Thinking in Clinical Trials Takes Shape in Europe

    There are several European initiatives exploring new thinking in clinical trials. “At last, the hunt is on for trials that fit science,” says Peter O’Donnell, who recently wrote an article on this topic in October’s Applied Clinical Trials. O’Donnell sums up several new initiatives to explore what changes ought to be made and lists a […]

    Read More »

  • December 10, 2015

  • IO360° Speaker Dr. Edith Perez on The People Behind the Data

    Conference Forum speaker Dr. Edith Perez, VP and Head of BioOncology, US Medical Affairs for Genentech recently wrote a blog piece that discusses the value of patients and how their involvement in clinical trials can help further research and development. “The people behind the data – they are the true heroes helping us find the […]

    Read More »

  • December 8, 2015

  • Making Clinical Trials a Care Option for Patients on PharmaTalk Radio

    At Dpharm US 2015, Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly hosted a talk show on Making Clinical Trials a Care Option for Patients to fantastic reviews. Dpharm Director, Valerie Bowling, welcomes Katherine as she hosts a similar session on Pharma Talk Radio. Katherine (Kathy) discusses how an organized multispecialty healthcare system, clinical research […]

    Read More »

  • December 7, 2015

  • Conference Forum Speaker Dr. Edith Perez on The People Behind the Data

    Conference Forum speaker Dr. Edith Perez, VP and Head of BioOncology, US Medical Affairs for Genentech recently wrote a blog piece that discusses the value of patients and how their involvement in clinical trials can help further research and development. “The people behind the data – they are the true heroes helping us find the […]

    Read More »

  • December 2, 2015

  • Clinical Trial Patient Speaks out in New York Times

    Although Stan Collender’s NYT’s Op-Ed contribution was published on June 19, 2015, we want to bring it more attention as his voice is so important in helping bridge the gap between really sick patients and clinical trials. From the New York Times: I HAVE a very rare and aggressive type of skin cancer — Merkel […]

    Read More »

  • November 23, 2015

  • FDA Approves Immunotherapy Drug Opdivo to Treat Renal Cell Carcinoma

    Congratulations to BMS who not only received FDA priority review status last week for Nivolumab (Opdivo) for Renal Cell Carcinoma, but have received today, FDA approval for the immunotherapy drug to treat the common form of kidney cancer in adults. According to The National Cancer Institute, an estimated 61,560 new cases and 14,080 deaths resulted […]

    Read More »

  • November 18, 2015

  • Lori Abrams, BMS on Diversity in Clinical Trials

    The purpose of medicines is to improve patients’ lives. Despite the increasing number and scope of patient involvement initiatives there are still challenges, such as diversity in clinical trials, that need to be addressed. Lori Abrams, Director of Patient Advocacy for Bristol Myers-Squibb shares her thoughts on the challenges with diversity in clinical trials and […]

    Read More »

  • November 16, 2015

  • 3rd Annual Patients as Partner’s Program Receives Patients Included Accreditation

    We are pleased to announce that the 3rd Annual Patients as Partners program is officially Patients Included accredited.  The mission of Patients Included is to provide conference organizers with a means of demonstrating that their events are committed to incorporating the experience of patients as experts in living with their condition while ensuring they are […]

    Read More »

  • November 12, 2015

  • How Patient Research Changed the Way We Present Clinical Trial Conferences

    Valerie Bowling, Executive Director of The Conference Forum discusses how her research with patients changed the way she looks at and presents all clinical trials conferences. ____________________________________________________ Five years ago, Greg Simon, who was the Head of Policy at Pfizer at the time and is now CEO of Poliwogg, asked our DPharm audience when was […]

    Read More »

  • November 11, 2015

  • DPharm Europe Venue Announced

    In the spirit of biomedical research investments to make the St Pancras / Kings Cross area of London the center for R&D innovation, we are pleased to announce that DPharm Europe will be held at the St Pancras Renaissance Hotel in London, UK. On one side of the hotel, the brand new Francis Crick Institute […]

    Read More »

  • November 10, 2015

  • Safety Elements of Cancer Immunotherapies Featured on Pharma Talk Radio

    In this episode of Pharma Talk Radio, we feature medical oncologist, Dr Anna Pavlick, Director of the Melanoma Program at the NYU Cancer Institute on Safety Elements of Cancer Immunotherapies. Dr Pavlick originally gave this presentation in June 2015 at the IO360 conference. We are pleased to bring this session to the public to help […]

    Read More »

  • October 30, 2015

  • Is Your CMO’s Role Evolving Fast Enough?

    The role of the Chief Medical Officer at pharmaceutical companies is evolving to improve patient care and outcomes. The position of Chief Medical Officer (CMO) is evolving as both the public and the broader medical community look for pharmaceutical companies to apply more ethical and scientific rigor to decision making. Some pharmaceutical companies are investing […]

    Read More »

  • October 15, 2015

  • Hear Agios CEO, Dr David Schenkein’s Keynote from the CMO East Summit

    At the 2015 Conference Forum’s Chief Medical Officer Summit in Boston, David Schenkein, MD, CEO, Agios provided a warm and personal keynote sharing his journey as a Physician CEO. In this recording of the session, gain an insight into Dr. David Schenkein’s journey from physician to CEO of a biopharmaceutical company leading the way in […]

    Read More »

  • October 10, 2015

  • Conference Forum Looks Forward to Attending Partnering for Cures November 1-3 in NYC

    We’re looking forward to joining our good friend, FasterCures for their 7th annual Partnering for Cures in New York City November 1-3. This outcomes-oriented meeting connects hundreds of decision-makers from across sectors in medical research with the express purpose of making collaboration happen – collaborations that must happen if we are to speed up the […]

    Read More »

  • October 7, 2015

  • Thank You to the Entire PODD Community!

    As the 5th annual PODD event comes to a close, we look forward to start the planning for the 6th annual conference. This year’s event scaled new heights in attracting more than 300 executives and featuring the widest range of drug delivery technologies from start up to established. The event also had a record number […]

    Read More »

  • September 21, 2015

  • Happy 3rd Birthday Transcelerate!

    Transcelerate turned three year’s old this month and we were delighted to recognize their milestone at DPharm last week. Transcelerate’s CEO, Dr Dalvir Gill brought the Dpharm audience up to speed  on collaborations with Pharma to drive patient-centricity and digital medicine. They launched in September 2012 as a non-profit organization to simplify and enhance R&D […]

    Read More »

  • September 21, 2015

  • A Big Thank You to the Entire DPharm US Community & Next Dates

    We would like to thank the entire DPharm US community for an intense and productive event. As one attendee put it,  s “the passion for innovation was palpable throughout the entire conference as well as learning more about innovations that are currently being implemented.” s It is an ambitious endeavor to present so many examples […]

    Read More »

  • September 11, 2015

  • Science 37 Awarded Disruptive Innovator of the Year at Dpharm 2015

    Boston, MA, Science 37 was named Disruptive Innovator of the Year at the 5th annual Dpharm event. Dr Noah Craft, Co-Founder and CEO of the company presented their platform, NORA which helps people anywhere participate in trials. Science 37 presented along side HealthCarePoint, Healthivibe, Tata Consultancy Services and Clinical Reach, a product of Parallel 6. Sarah […]

    Read More »

  • July 31, 2015

  • Consumer Electronics in Clinical Research on PharmaTalkRadio

    Join PharmaTalkRadio as we address and explore an update on what’s available, what’s capable and what’s working with consumer electronics in clinical research. We explore topics including, but not limited to: – How to scale new tools – The level of validation of different instruments – The impact of tools like the Apple Research Kit […]

    Read More »

  • July 24, 2015

  • 5 Questions for Dpharm Director, Valerie Bowling

    Jessica Rothenberg, Marketing Director at the Conference Forum, asks Valerie Bowling, Dpharm Director, five questions to give both past and future attendees an insight into DPharm 2015. Q: What are you most excited about for Dpharm 2015? A: I’m really look forward to seeing the diverse examples of innovation to advance clinical trials from so […]

    Read More »

  • July 12, 2015

  • Conference Forum Summer Outing to the Bronx Zoo

    This year our Conference Forum team voted for a day at the Bronx Zoo for a relaxing summer outing. We met at Columbus Circle for breakfast and drove up along the Hudson river to one of the best zoos in the world! Believe me, we have seen many. It was a lot of fun just […]

    Read More »

  • July 10, 2015

  • Meet The PODD 2015 Keynotes

    PODD: Partnership Opportunities in Drug Delivery 2015 is delighted to announce the keynote speakers. The annual keynote address with Dr Robert Langer, David H. Koch Institute Professor, MIT is scheduled to open the program on October 5th and the focus will be on nanotechnology. Following Dr Langer for the first time at PODD, we are […]

    Read More »

  • June 17, 2015

  • CRI Member to Chair Immuno-Oncology 360 Conference

    Originally published by the Cancer Research Institute: We’re pleased to share that Axel Hoos, M.D., Ph.D., a member of the CRI Scientific Advisory Council, co-director of our Cancer Immunotherapy Consortium Leadership Committee, and vice president for oncology research and development at GlaxoSmithKline, will be the chair and industry keynote for the Immuno-Oncology 360° Conference, which […]

    Read More »

  • May 13, 2015

  • Congratulations to Keynote Stéphane Bancel and Moderna for their #1 Disruptive Ranking by CNBC

    Congratulations to Moderna’s Stephane Bancel, our PODD 2015 keynote and Dr Tal Zaks, featured speaker at Immuno-Oncology 360° for leading the #1 ranked disruptive company according to CNBC. “The third annual Disruptor 50 list, CNBC features private companies in 16 industries—from aerospace to financial services to cybersecurity to retail—whose innovations are revolutionizing the business landscape. […]

    Read More »

  • May 6, 2015

  • Best Article on Partnering with Patients Authored by our Distinguished Speakers

    One of the best articles on partnering with patients in clinical research published. Lode Dewulf, MD, Roslyn Schneider, MD and Veronica Todaro, MPH, featured speakers at the Patients as Partners conference were among the authors who collaborated to make this article a reality. Congratulations to all. Abstract: The purpose of medicines is to improve patients’ […]

    Read More »

  • April 30, 2015

  • DPharm Makes Stuff Happen!

    We are so pleased to see another exciting outcome from the DPharm conference. Congratulations to TrialReach on making news in Forbes from their work with industry in registering patients in trials faster. Drug Companies Pin Hopes On TrialReach To Enroll Patients In Clinical Trials Faster Two years ago, Pfizer, Novartis, and Eli Lilly set aside […]

    Read More »

  • April 23, 2015

  • The Problem Solver: Cancer. Diabetes. Liver disease.

    April’s MIT Technology Review features a profile on PODD’s Annual Keynote Dr. Robert Langer. The piece titled, “The Problem Solver” explores the bioengineering challenges that Dr. Langer has and continues to work on. The Problem Solver by Amanda Schaffer When Robert Langer completed his doctorate in chemical engineering in 1974, he received around 20 offers […]

    Read More »

  • April 3, 2015

  • FDA’s Dr Richard Moscicki Confirmed for the Boston Chief Medical Officer’s Summit

    The Conference Forum is pleased to announce that Dr. Richard Moscicki, Deputy Center Director for Science Operations for the FDA is joining the Chief Medical Officer Summit. He joins the CMO Summit to help CMOs explore alternative regulatory pathways. Trends and case examples will be presented on: Breakthrough designation Fast Track Priority Review Orphan Designations […]

    Read More »

  • April 2, 2015

  • Creating An Advocacy Department To Hear The Voice Of The Patient

    Conference Forum speaker and advisor Lori Abrams was recently interviewed by Ed Miseta, Chief Editor, Outsourced Pharma and Clinical Leader on creating an advocacy department for BMS: Excerpt from Clinical Leader: When Lori Abrams was selected to be the head of advocacy, diversity and patient engagement for Global Development Operations at BMS, she took over […]

    Read More »

  • March 30, 2015

  • Patient Voice: The Key To Clinical Trial Success

    Ed Miseta, Chief Editor, Outsourced Pharma and Clinical Leader reviews Patients as Partners 2015. Last year when Valerie Bowling kicked off the inaugural Patients as Partners conference, she did so in the midst of a snowstorm. That unfortunately cut down on the number of attendees to a conference that covers a topic about which she is […]

    Read More »

  • March 30, 2015

  • Achieving Patient Centricity through Design Thinking

    Advances in science and digital technologies combined with empowered patients presents opportunities to redesign an outdated clinical trial business model that is more efficient, agile and patient centric.  The pharma/biotech industry has had a calling to be more patient centric.  Whether patient centricity is necessary for inspiration or a license to operate in a future […]

    Read More »

  • March 16, 2015

  • DIY PATIENT ENGAGEMENT

    This is the title of a recent article by BioCentury’s Steve Usdin. He summarizes how the House Energy & Commerce Committee is putting patient-focused drug development at the top of the 21st Century Cures discussion list. The FDA is backing this and encouraging industry to take an active roll, but how? How do we create […]

    Read More »

  • March 16, 2015

  • Conference Forum joins CISCRP at Medical Heroes Dinner

    Philadelphia, PA, March 15th, the Conference Forum attended CISCRP’s launch dinner to raise awareness for medical heroes in clinical research. The dinner was held at the Yards Brewing Company where we got to mingle over ales made from the same recipes from the American revolution and in particular founding father and fellow brewer, Thomas Jefferson. After […]

    Read More »

  • March 13, 2015

  • Patients As Partners in the News!

    Nature’s March 5th article “Training on trials: Patients taught the language of drug development” explores the relationship between industry and patients.  Ken Getz, co-chair of the Patients As Partners Event (March 16-17, 2015) spoke with nature about what opportunities are available for patients in the US. Nature excerpt below: Private organizations are increasingly extending invitations to […]

    Read More »

  • March 2, 2015

  • 10 Best Practices to be addressed at Patients as Partners

    Patients as Partners (March 16-17, 2015) will present: Communicating the importance of a leadership role around the patient in R&D Understanding the main issues that matter most to patients Building excellent communication and relationships with the patient community to build long-term solutions towards improving healthcare Creating and executing patient engagement strategies and ensure that the […]

    Read More »

  • February 20, 2015

  • DPharm Europe Launched in London to Address Transatlantic Innovation in Drug Development

    London, England, February 2015, DPharm Europe launched with over 20 examples of innovation from the US, Spain, UK, Sweden and France to demonstrate innovation to advance clinical trials. “What really made this event special was the level and amount of transatlantic collaboration on-site at DPharm Europe,” Valerie Bowling, DPharm Europe Director Over 125 drug development […]

    Read More »

  • February 19, 2015

  • Blue Sky Broadcast wins Dpharm Europe Idol

    Congratulations to Jim Bohlen and the Blue Sky Broadcast team for winning Dpharm Europe Idol at the premier launch of DPharm Europe on February 9th in London. Jim presented a brief overview on web-based training options for the training of clinical site personnel. During his presentations, he highlighted a number of innovative enhancements to increase […]

    Read More »

  • February 10, 2015

  • Conference Forum at 10 Downing Street for Transatlantic Innovation Meeting

    London, England: The Conference Forum helped organize the first ever meeting at 10 Downing Street dedicated to transatlantic innovation in drug development, patient access and the role of patients and big data. Healthcare policy specialists from Her Majesty’s government joined with a number of senior executives from across the pharmaceutical industry to discuss the central theme of how we can work together to accelerate drug […]

    Read More »

  • February 2, 2015

  • Medical Heroes Appreciation Dinner to Honor Patients in Clinical Research

    CISCRP in collaboration with the Patients as Partners Conference team are excited to launch the first Medical Heroes Appreciation Dinner to celebrate the people who participate in clinical research. Hosted by Ken Getz, Founder of CISCRP, the event takes place on March 15th at the Yards Brewing Company in Philadelphia. Proceeds from this event will […]

    Read More »

  • January 28, 2015

  • Patient Advocates: Expanding Their Role in Conducting Successful Clinical Trials

    Patient advocacy organizations have grown over the past 25 years in affecting legislative and policy issues to fight for the patient voice and rights across numerous therapeutic areas. Patient advocates have earned respect for their work in lobbying for legislation that ensures high-quality patient care, for raising millions of dollars for research, and for increasing […]

    Read More »

  • December 17, 2014

  • Will Patients be Able to Pay to Get into a Clinical Trial?

    Frustrated that a promising therapy for a rare cancer was sitting in a freezer due to the lack of a relatively modest amount of funding, author Alexander Masters helped lead a campaign to crowd-fund a clinical trial: the result, iCancer.org.uk. The money required was indeed raised – by one wealthy individual primarily, in return for being […]

    Read More »

  • December 12, 2014

  • The Conference Forum Celebrates 2014!

    To celebrate our hard work and many accomplishments over holiday cheer as the year comes to an end, we closed our doors for the afternoon of December 11th and ventured to the Upper West Side for a Druze feast. Between launching new conferences, growing events, building partnerships, adopting and implementing more technology and moving offices, we […]

    Read More »

  • December 8, 2014

  • Seven New Government Drug Pricing Announcements Covered at the GDP Forum

    In addition to the expanded coverage on MDRP, 340B, Tricare, Medicaid Managed Care, AMP Final Rule, HRSA guidance & price reporting, rise of contract pharmacies, new state reporting requirements and government and commercial contracting rules, we are pleased to let you know that the GDP Forum will also address these six important announcements: #1: OIG […]

    Read More »

  • December 5, 2014

  • ePharmaSolutions is helping patients find the right studies

    90% of patients who respond to recruitment ads never get into that study. That’s a percentage ePharmaSolutions is changing. After being turned away from a study many patients don’t know where to look for alternatives. At the Patients as Partners event, Lisa LaLuna of ePharmaSolutions and  DPharm Idol 2014 winner shares information on ReferralPlus using […]

    Read More »

  • December 4, 2014

  • Why it’s important to present an event on Government Drug Pricing?

    Why it’s important to present an event on Government Drug Pricing? Since 2012, the Government Pricing industry primarily focused its energy on Medicaid as they awaited the AMP Final Rule. The changes with the 340B program and the shift in payer mix to MMCOs caused operational challenges, increased financial, compliance and contractual burdens. With the increase […]

    Read More »

  • December 3, 2014

  • Building a European Adaptive Trial Delivery Machine for Dementia @ Dpharm Europe

    We are so pleased to welcome Professor Craig Ritchie, Professor of the Psychiatry of Ageing, Centre for Clinical Brain Sciences University of Edinburgh and Visiting Professor Imperial College London to the DPharm Europe conference. DPharm Europe features global examples of disruptive innovation in clinical trials. Not all innovation is disruptive, but in the case of […]

    Read More »

  • December 3, 2014

  • A Mother’s Courage Opens Patients as Partners Event!

    We are so pleased to welcome, Pat Furlong, Founding President and CEO of PPMD to the Patients as Partners event. Pat will open the program with the patient view on participating in clinical trials. Patients as Partners is dedicated to: 1. Understanding and incorporating the patient’s voice in designing clinical trials 2. Vastly improving the patient’s […]

    Read More »

  • November 17, 2014

  • 10 Questions for MIT’s Dr Robert Langer on Business, Science & Baseball

    Valerie Bowling, Executive Director, The Conference Forum recently interviewed MIT’s Professor Dr Robert Langer at the PODD Drug Delivery conference to get his views on entrepreneurship, leadership, start ups, the intersection of academia with business and yes even baseball. It’s always an honor and a privilege to interview Dr Langer, a person who takes science […]

    Read More »

  • October 30, 2014

  • GCT Speaker, Dan McDonald, DAC Patient Recruitment Services featured on Clinical Leader

    Dan McDonald has been around global trials for more than 14 years, spending considerable time traveling internationally and working for US and Asian based clinical research organizations. In his current role as director of business development for DAC Patient Recruitment Services, he works with biopharmaceutical companies to develop and execute customized strategies for their site […]

    Read More »

  • October 2, 2014

  • Keynotes & VIP Guest Presentations at the Chief Medical Officer Summit West

    Jazz Pharmaceuticals, OncoMed Pharmaceuticals, and former head of the EMA to deliver keynotes and featured presentations at CMO West on November 3-4, 2014 in San Francisco, CA. Dr Tobias from Jazz Pharmaceuticals and Dr Dupont from OncoMed bring us through the journey of the life of a CMO pre and post IPO, the trials and […]

    Read More »

  • October 2, 2014

  • New Drug-Delivery Capsule May Replace Injections

    Fantastic article to share from MIT on a pill coated with tiny needles that can deliver drugs directly into the lining of the digestive tract. Could this truly replace injections and instead one can swallow itsy bitsy needles with no pain and problem? We do look forward to discussing this topic along with so many interesting drug […]

    Read More »

  • September 29, 2014

  • DrugDev’s Review on DPharm: Disruptive Innovations to Advance Clinical Trials

    There were so many inspirational talks at this year’s conference it was hard to know where to start. So, we decided to split this post into three main themes: patient-centricity, ‘real-world’ integration into research, and innovative trial design. (For more on DrugDev’s review, see link below: http://www.drugdev.org/2014/09/19/disruptive-innovations-conference-review/  

    Read More »

  • September 24, 2014

  • Congresswoman Diana DeGette Discusses Path 2 Cures Initiative at DPharm

    We were honored to welcome Congresswoman Diana DeGette as our Keynote speaker at DPharm on September 12, 2014. Rep. DeGette is helping lead a landmark initiative dedicated to creating a path to 21st century cures. For the first time ever, Congress is taking a comprehensive look at what can be done to accelerate the pace […]

    Read More »

  • September 19, 2014

  • Bringing the Patient Voice to Disruptive Innovations Conference

    A huge thanks to our patient speaker, Julie Flygare for her excellent presentation on “How a Patient Helped to Define a New Clinical Endpoint in Narcolepsy.” Diagnosed with narcolepsy with cataplexy in 2007, award-winning author and founder of Project Sleep, Julie shared her story to an audience of just over 300 disruptive thinkers in drug […]

    Read More »

  • September 17, 2014

  • Congratulations to ePharmaSolutions on Disruptive Innovator of the Year at DPharm 2014!

    Congratulations to Lisa La Luna, SVP, Corporate Development and Implementation and her team on winning Disruptive Innovator of the Year at DPharm 2014. They won for their excellent presentation on paperless clinical trials. The judges included: Andreas Koester, MD, PhD
VP, Clinical Trial Innovation & External Alliances, Janssen Craig Lipset, MBA, 
Head of Clinical Innovation, R&D, […]

    Read More »

  • August 27, 2014

  • Why Walgreens is Dedicating Resources to Clinical Research?

    Dr Howard Golub was recently appointed in a new role as Vice President, Clinical Research at Walgreens. We caught up with Dr Golub who shared a bit about his plans to build a research team to handle some pre-approved drugs, but mostly post approvals.  This new area for Walgreens is part of their overall plan […]

    Read More »

  • August 26, 2014

  • Congratulations to our Jennifer Moran on her Big Win!

    Jennifer Moran, Production Assistant at the Conference Forum is also a star Irish football player on a New York team. Over the weekend, she helped lead her team to victory at the All-Ireland JFC semi-final in Ashbourne, Ireland.  Jennifer is back in New York, but not for long as she will be returning to Ireland […]

    Read More »

  • August 26, 2014

  • Medtech Boston talks with Valerie Bowling about Conference Forum events

    If you’re interested in disruptive innovations in clinical trials or drug delivery, Boston is prime real-estate. That’s why The Conference Forum will be hosting four major events in September and October 2014: Mobile and Clinical Trials; Global Clinical Trials; DPharm: Disruptive Innovations to Advance Clinical Trials; and Partnerships in Drug Delivery. We caught up with […]

    Read More »

  • August 18, 2014

  • Pharma Talk Radio on What’s Happening with Digital and Clinical Trials?

    Pharma Talk Radio features Donald Jones, Chief Digital Officer, Scripps Translational Science Institute as he talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma. […]

    Read More »

  • August 11, 2014

  • Speakers Recognized by PharmaVoice100

    PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. These people actively demonstrate what it means to think bigger and lead with passion and integrity. They are nominated by thousands of PharmaVOICE readers throughout the year. We are so pleased to see several of our speakers make […]

    Read More »

  • August 6, 2014

  • The Biggest Challenges in Conducting Global Clinical Trials

    The Biggest Challenges in Conducting Global Clinical Trials By Chris Gallen Trials have to test the hypothesis that the treatment differs from placebo or another treatment. To do that you have to compare results from the groups. The key to your ability to do so is the variance between the groups. If you have two […]

    Read More »

  • July 16, 2014

  • Rep. Diana DeGette (D-CO) Addresses 21st Century Cures at Dpharm

    21st Century Cures is a new initiative that aims to accelerate the pace of cures and medical breakthroughs in the United States. Rep. Diana DeGette (D-CO) and House Energy and Commerce Committee Chairman Fred Upton (R-MI) are leading this initiative. This is a rare effort in Congress and we are thrilled to have Diana DeGette as […]

    Read More »

  • July 14, 2014

  • Collaborative Clinical Trials (Lung-MAP) to be Featured at Dpharm

    Dr Jeff Allen of Friends of Cancer Research joins Dpharm to share the journey of a new paradigm in clinical research. Lung Cancer Master Protocol (Lung-MAP) is the product of years of collaboration with government, research institutions, patient advocacy groups, and industry. Will cooperative trials provide a more efficient model?  On Sept 11th in Boston […]

    Read More »

  • July 9, 2014

  • Summer Outing in Coney Island Brooklyn

    On Tuesday, July 8th, we closed our doors and traveled to Brooklyn and spent a summer company outing in Coney Island. Coney Island has been attracting visitors to its beach and amusement parks since the 1830s where people would travel by carriage roads and stream ships. It is the home of Nathan’s Famous hot dogs […]

    Read More »

  • June 6, 2014

  • Dr Joris Van Dam, Novartis Appointed Chair of the Inaugural Mobile and Clinical Trials Event

    The Conference Forum is thrilled to announce the appointment of Joris Van Dam, PhD, Strategic Projects Leader, Pharmaceutical Development at Novartis as the Chair for the inaugural Mobile and Clinical Trials event. This new one-day program taking place September 10th in Boston helps drug developers get their arms around the mobile/digital clinical trial landscape. Topics addressed include […]

    Read More »

  • June 2, 2014

  • Scouting External Drug Delivery Technology Panel is Confirmed for PODD 2014

    Richard Korsmeyer, PhD, Senior Research Fellow, Head of External Technology & Collaborations at Pfizer will moderate the opening panel at PODD on October 14th in Boston on Scouting External Drug Delivery Technology. Key discussion points include: Understanding the process and specific technology interest Methods of sourcing external delivery technologies and DDS-enabled product Key factors and criteria used during […]

    Read More »

  • May 21, 2014

  • Komathi Stem named 4th co-chair to DPharm 2014

    The Conference Forum is thrilled to announce the appointment of Komathi Stem, Senior Director, Product Development, Innovation Lead at Genentech as the 4th co-chair for DPharm 2014. Komathi is a Biomedical Engineer with over 20 years of broad Pharma/Biotech industry experience ranging from Sales, Medical Affairs and Clinical Operations. She has built and led field […]

    Read More »

  • March 11, 2014

  • A Clinical Trial is Like a Restaurant?

    From the Rare Disease Report: by James Radke A Clinical trial needs to be more like a restaurant.  Let me explain…. I’m here at the Patients As Partners and have listened to several excellent presentations explaining different methods  that companies are using to help engage patients in the clinical trial process. All the presentations have […]

    Read More »

  • March 7, 2014

  • MMG Wins Patient Idol At Patients as Partners Event

    The 1st Annul Patients as Partners event brought together industry, patients, patient advocacy, sites, the FDA, academia and service providers. The program took a careful view of the patient experience and how we engage with patients across the entire clinical trial continuum.  Patients as Partners featured a “Patient Idol” section where four companies presented their […]

    Read More »

  • February 20, 2014

  • Pharmacy Product Expert to Introduce CIS State Initiative at Medicaid Rebate Summit

    PHILADELPHIA, Pa., Feb. 19, 2014 – Compliance Implementation Services (CIS), a leading life sciences regulatory advisor and implementation firm, has hired Sharon H. Greeson, R.Ph as Strategic Consultant, Government Pricing and Programs to support CIS’ state Medicaid service offerings and lead its “State Medicaid Initiative”, which will help pharmaceutical manufacturers with their Medicaid and Medicaid […]

    Read More »

  • February 14, 2014

  • 340B Sessions at the Medicaid Rebate Summit Address new OIG reports and more

    340B Session at Medicaid Rebate Summit to address the Contract Pharmacy Arrangements in the 340B Program and more. The 340B drug discount program is receiving unprecedented attention from Congress, regulators and the national media. With the first of its three planned reports confirming industry fears, the MRS Summit is presenting full coverage on the updates to […]

    Read More »

  • February 10, 2014

  • Mylan & Iroko Co-Charis Discuss the Upcoming MRS Summit

    As co-chairs of the 2nd Annual Medicaid Rebate Summit we wanted to share some of the anticipated highlights with you. The organizers have built on the success from last year’s event to line up a diverse group of industry experts and a wide-ranging agenda. Highlights from this year’s program include: Full coverage on 340B covered […]

    Read More »

  • January 30, 2014

  • Barriers and Limitations in Engaging Patients in Clinical Trials

    Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest […]

    Read More »

  • January 20, 2014

  • Patients As Partners State of the Industry Address

    How good are we at keeping patients is the focus of the State of Address being delivered by Ken Getz, Director of Sponsored Research, Tufts CSDD and Founder, CISCRP. Ken’s State of Address breaks down the pharma-patient relationship and identifies: Metrics specific to recruitment and retention effectiveness Root causes of poor enrollment performance Opportunities to […]

    Read More »

  • January 13, 2014

  • The Medicaid Rebate Summit Keynotes

    2014 Drug Channels Keynote Adam J. Fein, PhD President Pembroke Consulting     Dr Fein will be opening the MRS 2014 event on February 26th with a keynote address on how Medicaid will Shape Pharma’s Future. More specifically, Dr Fein will address: Key drug channel trends New organizational and
 compliance challenges from
 market developments How […]

    Read More »

  • November 27, 2013

  • The Conferences Forum Launches Patients as Partners Event

    Patients as Partners (March 3-4, 2014, Philadelphia) takes a comprehensive view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators. The Conference Forum is proud to present Patients as Partners with CISCRP’s […]

    Read More »

  • November 25, 2013

  • Pfizer launches trial data sharing service

    Pfizer has launched a first-of-its-kind project that enables patients who have participated in clinical trials the ability to download their individual clinical data. Using the Blue Button standard, an initiative first launched by the White House in 2010, patients “will be empowered to use the data to improve their overall health and wellness, from sharing […]

    Read More »

  • November 7, 2013

  • Change is Coming to Clinical Trials

    Jerry Matczak, Community Manager for the Lilly Clinical Open Innovation team provides us with a few key takeaways from this year’s conference: 1. Pharma’s commitment to collaboration is real.  As evidence, look to TransCelerate BioPharma, Inc.,  a non-profit consortium of 17 pharmaceutical companies who are working together to solve common problems in drug research and development. After only one year of operation, […]

    Read More »

  • October 29, 2013

  • The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit

    The 2nd Annual Medicaid Rebate Summit will address the interpretation of the anticipated Final Rule and the larger implications of Medicaid expansion including the financial, operational and legal impact.   In anticipation of the Final Rule and Medicaid expansion, the Conference Forum announced the launch of the 2nd annual Medicaid Rebate Summit for January 22-23 in Washington […]

    Read More »

  • October 18, 2013

  • A Peek at GCT 2012

    Presentation from 3rd Annual Executing Global Clinical Trials conference, Boston, MA September 2012 from Eileen Daniel, Director, Clinical & Data Operations, Endo Pharmaceuticals

    Read More »

  • October 15, 2013

  • A Peek at CMO East 2013

    A Peek at the Chief Medical Officer Summit East 2013, May 5 – 6, 2013, Boston, MA. Presented by: Jeff Sherman, CMO & EVP, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma, Inc.

    Read More »

  • October 7, 2013

  • A Peek at CMO East 2013

    A presentation on “Strategic Public-Private Partnership with the FNIH” from the Chief Medical Officer Summit East 2013, May 5 – 6, 2013, Boston, MA. Presented by: Steve Hoffmann, Scientific Program Manager,The Biomarkers Consortium ,Inflammation and Immunity Steering Committee Steve Hoffmann from ConferenceForum

    Read More »

  • October 4, 2013

  • The Need and the Challenge of Delivering Innovative Topical Ophthalmic Treatments

      Kim Brazzell, MD, CMO and  Hongming Chen, VP, Research, from Kala Pharmaceuticals share their thoughts on “The Need and the Challenge of Delivering Innovative Topical Ophthalmic Treatments”     The need for improved ocular disease therapies is large and growing due to the increasingly aging population. Many currently marketed therapies are associated with frequent dosing or […]

    Read More »

  • October 2, 2013

  • Innovations in Bioavailability Enhancement with Lipid-based Formulation Technology

      Eduardo Jule, Ph.D., Senior Manager, Capsugel, shares his thoughts on “Innovations in Bioavailability Enhancement with Lipid-based Formulation Technology” Lipid-based formulations (LBF) have become a well-established strategy to improve bioavailability of poorly soluble compounds. With a pipeline of increasingly complex drug candidates with bioavailability challenges, pharmaceutical companies are turning to Capsugel’s Dosage Form Solutions team […]

    Read More »

  • September 30, 2013

  • DPharm Disruptive Innovator of the Year Announced

    The partnership between Medidata Solutions and Spaulding Clinical Research is chosen as the winner of DPharm“American Idol”   New York, New York: Medidata Solutions and Spaulding Clinical Research were honored with the title of Disruptive Innovator of the Year at the Dpharm Disruptive Innovations conference on September 20, 2013 for their collaboration on a novel […]

    Read More »

  • September 30, 2013

  • Forging A Successful Innovation Partnership

    Sven Stegemann, Ph.D., President, Geriatric Medicines Society, speaker at this years PODD event shares his thoughts on “Forging A Successful Innovation Partnership” The word “innovation” is used over and over again by those in the drug delivery and pharmaceutical industries. However, there are differences in opinion between the two groups as to what makes something “novel” […]

    Read More »

  • September 13, 2013

  • Transdermal Delivery Solutions Corp. to present breakthrough technology at PODD 2013.

    PODD attendees will be among the first to learn about a revolutionary spray-on drug delivery system for the treatment of low testosterone. Kenneth Kirby, president and CEO of Transdermal Delivery Solutions Corporation (TDSC), will introduce his patented treatment technology during his talk titled, “Innovations in Transdermal Drug Delivery,” during the noon session on Friday, October […]

    Read More »

  • September 9, 2013

  • A Peek at Dpharm 2012

    Disruptive Innovation presentation from 2nd Annual Disruptive Innovations to Advance Clinical Trials, Sept 2012, Boston, MA on ‘Bringing Clinical Research into Clinical Practice’ by Joris van Dam, Translational Sciences Strategic Project Leader, Novartis A Peek at Dpharm 2012 from ConferenceForum

    Read More »

  • September 6, 2013

  • A Peek at CMO East 2013

    A presentation on ‘A fully integrated life cycle healthcare services provider’ from the Chief Medical Officer Summit East 2013, May 5 – 6, 2013, Boston, MA. Presented by: Jeffrey Spaeder, Quintiles A Peek at CMO East 2013 from ConferenceForum

    Read More »

  • August 28, 2013

  • A Peek at GCT 2012

    Presentation from 3rd Annual Executing Global Clinical Trials conference, Boston, MA September 2012 from Mitchell Katz, Ph.D. Executive Director, Medical Research Operations Purdue Pharma L.P. A Peek at GCT 2012 from ConferenceForum

    Read More »

  • August 19, 2013

  • A Peek at Dpharm 2012

    Presentation on ‘A new model to reduce waste in clinical development’ from the 2nd Annual Disruptive Innovations to Advance Clinical Trials, Sept 2012, Boston, MA  by  Chas Bountra, Chief Scientist, Structural Genomics Consortium A Peek at Dpharm 2012 from ConferenceForum

    Read More »

  • August 13, 2013

  • A Peek at PODD 2012

    PODD-Partnership Opportunities in Drug Delivery presentation from October 2012, Boston, MA on “Strategies for Developing and Commercializing Biobetters & Biosimilars” by Phil Smith, PhD, Founder, PNPSmith advisors, LLC.

    Read More »

  • August 9, 2013

  • A Peek at the Chief Medical Officer Summit East 2013

    A presentation on ‘Two-Stage Adaptive Design in Late Stage Trials- Making best use of scarce resources’ from the Chief Medical Officer Summit East 2013, May 5 – 6, 2013, Boston, MA. Presented by: M. Scott Harris, MD, of Middleburg Consultants & Georgetown University. Scott Harris from ConferenceForum

    Read More »

  • August 7, 2013

  • A Peek at Dpharm 2012

    Disruptive Innovation presentation from 2nd Annual Disruptive Innovations to Advance Clinical Trials, Sept 2012, Boston, MA on ‘Moving Beyond the Talk’ by Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly Thomas Krohn – Dpharm 2012 – Disruptive Innovation: Moving Beyond the Talk from ConferenceForum

    Read More »

  • July 30, 2013

  • A Peek at GCT 2012

    Keynote Presentation from 3rd Annual Executing Global Clinical Trials conference, Boston, MA Septemvber 2012 on Emerging Markets by Novartis; Regional Medical Director, OTC, GEM, Helmut Wolf, MD

    Read More »

  • July 24, 2013

  • A Peek at Dpharm 2012

    A Presentation on “Using Innovative (and Sometimes Unlikely) Partnerships to Drive Measureable Progress in Global Health R&D by David Shoultz, from the Bill & Melinda Gates Foundation, at the 2nd Annual Disruptive Innovations to Advance Clinical Trials 2012.  Dpharm 2012: Using Innovative Partnerships to Drive Measurable Progress in Global Health R&D from ConferenceForum

    Read More »

  • July 22, 2013

  • Thoughts on PODD Industry Keynote: The Future of BioTherapeutics

    Mak Jawadekar, PhD, formerly Director, Portfolio Management & Analytics of Pfizer and Scientific Board Member of Oncobiologics and Livwell Therapeutics shares his thoughts on John Ludwig’s PhD (SVP, BioTherapeutics Pharmaceutical Sciences, Pfizer) upcoming presentation at PODD, October 10-11th, 2013, Boston, MA. John’s presentation on the Future of BioTherapeutics and the importance of drug delivery will shed light on: The growing importance […]

    Read More »

  • July 11, 2013

  • The ‘What Ifs’ of nanoparticles & nanomedicines with Dr. Omid Farokhzad

    Featured PODD nanomedicine panelist & leading researcher, Dr. Omid Farokhzad, Associate professor of Anaesthesia, Harvard University speaks with Simon Constable, Wall Street Journal Columnist on Digits. He explains the what ifs of nanoparticles and nanomedicines such as: What if you could swallow a pill that conducts surgery? What can the world’s tiniest robots do to DNA […]

    Read More »

  • July 11, 2013

  • What’s in Pete Valenti’s innovation arsenal for you?

    Dpharm 2013 speaker Pete Valenti, from Insigniam, had the following to say in a recent article on Innovation: In studies by the Product Development Management Association (PDMA), only one of every nine new product concepts becomes a commercial success. How do you increase the odds in your favor? Take a cue from Pete Valenti, who has more […]

    Read More »

  • July 10, 2013

  • Xeris is Looking Forward to PODD 2013

    Xeris is looking forward to participating in the PODD conference again this year, especially since the  event aligns with our goal to pursue partnering opportunities as part of our XeriScreen™ program.  With our novel formulation technologies, XeriSol™ and XeriJect™, we strive to develop a number of  therapeutics and delivery technologies for ready-to-use, low-volume, subcutaneous injections […]

    Read More »

  • June 18, 2013

  • Chief Medical Officer Summit for Biotechs Goes West

    After the successful launch of CMO East, The Conference Forum is thrilled to announce that Chief Medical Officers on the West Coast will have their own conference, November 4-5, 2013 at the Marines Memorial Club & Hotel. New York, NY, June 17, 2013 With the huge success of CMO East, we are thrilled to announce […]

    Read More »

  • June 14, 2013

  • Scientific Luminaries to Keynote at 3rd Annual PODD

    Industry leaders and life science legends Dr Robert Langer and Dr George M. Whitesides keynote the Partnership Opportunities in Drug Delivery Conference presented by the Conference Forum. The event presents a strategic level program on pharma/biotech drug delivery partnership opportunities. New York, New York (PRWEB) June 12, 2013 The Conference Forum is pleased to announce […]

    Read More »

  • May 23, 2013

  • Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches

    The Disruptive Innovations to Advance Clinical Trials (DPharm) event is the definitive conference committed to transforming the clinical trial enterprise with bold ideas through an original interactive format. The entire program is dedicated to presenting disruptive ideas to greatly enhance the industry’s ability to achieve clinical operational excellence.   New York (PRWEB) May 22, 2013 […]

    Read More »

  • January 16, 2013

  • Monday’s Medicaid Announcement from the CMS

    The Centers for Medicare & Medicaid Services published a rule Monday detailing how states should coordinate certain elements of health exchanges and Medicaid. The New York Times: States Will Be Given Extra Time To Set Up Exchanges Under the law, the secretary of health and human services was supposed to determine “on or before Jan. […]

    Read More »

  • January 16, 2013

  • Blog Posting from Audrey Erbes about New Paradigms 2013

    A blog posting regarding the recent New Paradigms to Fund Life Science Innovation conference. Jan 7-9th, 2013 in the Marines Memorial Club & Hotel, San Francisco.  Observations: JP Morgan Healthcare Week from Audrey Erbes JP Morgan’s Healthcare Conference is no longer the sole life science event of value in San Francisco as in earlier years. […]

    Read More »

  • January 4, 2013

  • Blog Posting from Audrey Erbes for New Paradigms 2013

    A blog posting regarding the upcoming New Paradigms to Fund Biotech conference. Jan 7-9th, 2013 in the Marines Memorial Club & Hotel, San Francisco.  Hi, As promised I’ve collected all the events for the first quarter of 2013 so you can carry out your New Year’s resolution to attend more industry programs to increase your […]

    Read More »

  • December 11, 2012

  • NAMD Director Points To CMS’ Balancing Act In Medicaid Expansion Policy

    A Blog posting from our Media Partner, InsideHealthPolicy.com, visit here for a free trial. As long as the Obama administration views states’ assertions that they will not expand Medicaid as saber rattling — similar to certain states’ negative reaction to stimulus funds that were ultimately accepted — the administration has no reason to allow for a partial expansion […]

    Read More »

  • December 5, 2012

  • Medicaid Rebate Summit Additional Highlights Announced – Early Bird Ends in 3 Days

    New York, NY: The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, announced the latest highlights and additions to the Medicaid Rebate Summit on February 14-15, 2013 in Washington, DC.  The Summit opens with Alice Valder Curran of Hogan Lovells on the anticipation of the Final Rule and is followed by an enforcement panel of US Attorney Offices. Highlights: The […]

    Read More »

  • December 4, 2012

  • A New Medicaid Rebate Summit Announced for Early 2013

    The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, is presenting a Medicaid Rebate Summit on February 14-15, 2013 in Washington, DC.  The Summit opens with Alice Valder Curran of Hogan Lovells on the anticipation of the Final Rule and is followed by an enforcement panel of US Attorney Offices. The Summit features Health Care Association insights on health care […]

    Read More »

  • November 27, 2012

  • Our Keynote Dr Langer recognized in NYTs for his Innovation

    Hatching Ideas, and Companies, by the Dozens at M.I.T. How do you take particles in a test tube, or components in a tiny chip, and turn them into a $100 million company? Dr. Robert Langer, 64, knows how. Since the 1980s, his Langer Lab at the Massachusetts Institute of Technology has spun out companies whose products treat cancer, diabetes, […]

    Read More »

  • November 2, 2012

  • A Peak at New Paradigms 2012

    A Presentation on an Investors Perspective on Changing Paradigms in Outsourcing This Presentation was delivered by Liz Stoner, MPM Capital, at New Paradigms to Fund Biotech 2012, San Francisco, CA.

    Read More »

  • October 18, 2012

  • A Peak at New Paradigms 2012

    A Presentation on Pharmaceutical Pricing. This Presentation was delivered by Kent Rogers at New Paradigms to Fund Biotech 2012, San Francisco, CA.

    Read More »

  • October 11, 2012

  • Disruptive Innovation in Pharma – Time to get on board!

    Thomas Krohn, Director, Eli Lillys Clinical Open Innovations thoughts on Dpharm 2012. Is pharma willing to disrupt itself?  What does disruption look like in pharma?  If a change is good for everyone, is it really disruptive?  These and other questions were explored during the 2 day Disruptive Innovations to Advance Clinical Trials Conference in Boston last month. […]

    Read More »

  • October 10, 2012

  • The 2nd Biggest Secret to Innovation

    Part two of Rob Wright, Chief Editor of Life Science Leaders, blog. Jon Platt, healthcare sector leader for ?WhatIf! Innovation, conducted a presentation at the Conference Forum’s (www.conferenceforum.org) 2nd Annual Disruptive Innovation to Advance Clinical Trials for Pharma, Biologics & Devices conference in Boston. He provided the two biggest secrets to innovation – the first […]

    Read More »

  • October 4, 2012

  • Disruptive Innovations to Advance Clinical Trials: Thoughts & Themes

    A blog posting from one of our 2012 Dpharm attendees: Rahlyn Gossen from Rebar Interactive. If you are often frustrated by the pace of progress in clinical trials,there’s hope. Or at least that’s my feeling after attending the 2nd annual Disruptive Innovations to Advance Clinical Trials conference in Boston. It was a truly refreshing experience. And given […]

    Read More »

  • October 3, 2012

  • The 2 Biggest Secrets Of Innovation

    A blog posting about our 2012 Dpharm program from media partner Rob Wright, Chief Editor of Life Science Leader At this year’s 2nd Annual Disruptive Innovation to Advance Clinical Trials for Pharma, Biologics & Devices conference in Boston, I had the opportunity to sit through a presentation by Jon Platt, healthcare sector leader for ?WhatIf! […]

    Read More »

  • September 24, 2012

  • Attending Companies at PODD 2012

    An update on some of the companies in attendance on October 1-2nd 2012! Ratio Drug Delivery, Allergan, Catalent Pharma Solutions, MIT, Thomas, McNerney & Partners, Astrazeneca, Hovione, Momenta Pharmaceuticals, Pfizer, Inc., Eli Lilly, MannKind Corp, University of Nebraska Medical Center, Xeris Pharma, Vertex Pharmaceuticals, Amgen, PhaseBio Pharmaceuticals Inc., FluGen Inc., Aptalis, Kala Pharmaceuticals/ Polaris Venture […]

    Read More »

  • September 21, 2012

  • Pictures from New Paradigms 2012

    Here are some pictures from the 2012 New Paradigms to Fund and Move Drug Development Conference held on January 11th – 12th, 2012, in the Marines Memorial Club & Hotel, San Francisco.

    Read More »

  • September 20, 2012

  • Jeri Burtchell, Gilenya & Me, gives her impressions of Disruptive Innovations 2012

    THURSDAY, SEPTEMBER 20, 2012 My Impressions of the Disruptive Innovations Conference in Boston – Part 3: The Interview If you are just tuning in, you can read parts 1 and 2 of My Impressions of the Disruptive Innovations Conference here: Part 1: http://gilenya.blogspot.com/2012/09/my-impressions-of-disruptive.html Part 2: http://gilenya.blogspot.com/2012/09/my-impressions-of-disruptive_19.html The evening of Day 1 of the event found me networking […]

    Read More »

  • September 6, 2012

  • Less than one week to Dpharm 2012! Two New Speakers Announced

    Two new speakers have joined the distinguished speaking faculty for the 2nd Annual Disruptive Innovations to Advance Clinical Trials Conference. Penny Mohr, Vice President, Program Development, Pragmatic Studies and Applied Solutions Group, Center for Medical Technology Policy, and Richard Murray, MD, Vice President, Global Center for Scientific Affairs, Merck, both of who will be speaking […]

    Read More »

  • August 16, 2012

  • Clinical Trials Have Gone Global – Are You Up to Speed?

    A Blog post from our Media Partner PharmaVoice Clinical studies are becoming more complex, and are reaching across the globe at a progressively more rapid rate. Sponsors are seeking increased access to patients and investigators, better R & D solutions, and improved efficiencies. Navigating these waters can be treacherous. For most, there are more questions […]

    Read More »

  • August 14, 2012

  • Four Weeks Left to Register for Dpharm 2012!

    Please note, the official conference venue is sold out of sleeping rooms. Please refer to our website for alternative nearby hotels. Out of the Box Registration Options: Partial and Full Scholarships available for early stage biotechs Group Discounts for three or more from the same company, 15% Off $125 Special rate for American Idol Technology […]

    Read More »

  • August 9, 2012

  • Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D

    New York, NY — Pharmaceutical and biotech companies are preparing to hear more than 25 presentations, ranging from key behaviors that drive innovation to applying disruptive approaches to achieve pragmatic clinical trials, at the 2nd Annual Disruptive Innovations to Advance Clinical Trials (DPharm) conference. The event is scheduled for September 13-14, 2012 at the Fairmont […]

    Read More »

  • August 9, 2012

  • A Peak at DPharm 2011

    NEED CODE FOR SLIDE A Presentation on Challenges and Opportunities in Clinical Development. This Presentation was delivered by Greg Simon at Dpharm: Disruptive Innovations to Advance Clinical Trials for Pharma, Biologics & Devices 2012. For the 2012 Program Agenda and info please visit http://www.dpharmconference.com/

    Read More »

  • July 27, 2012

  • Globalization – Ethical & Business Considerations in Clinical Research

    The ACRO publishes a white paper on Global Clinical Trials. This report analyzes the current state of global clinical research and the role that biopharmaceutical companies and their clinical research organization (CRO) partners play in ensuring that the dual goals of trial safety and quality are met. With the changing landscape for CROs, the report […]

    Read More »

  • July 27, 2012

  • Coming up on DPharm 2012!

    Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly just joined the Disruptive Innovations speaking faculty where he will provide an opening address on: Disruptive Innovation: Moving Beyond the Talk A case for action to move beyond incremental improvement Concrete opportunities for disruptive innovation in clinical development Are you on board? The tide is rising.

    Read More »

  • July 26, 2012

  • Disruptive Innovations 2012 at a Glance!

    Disruptive Innovations 2012 at a Glance! At the Disruptive Innovations to Advance Clinical Trials 2nd annual event, you will meet industry leaders determined to reinvent clinical trials. This is an outcomes-focused program with over 30 examples of bold innovative strategies and the application of technology for real changes in clinical trial advancements. Taking place in Boston, MA on September 13-14, the […]

    Read More »

  • July 16, 2012

  • Another Peak at PODD 2011

    A Presentation on Transforming a New Drug or Technology into a Marketed Product. This Presentation was delivered by Mark J. Kontny, PhD, of Patheon Inc. during the 2011 PODD program.

    Read More »

  • July 13, 2012

  • Combating Drug Resistance

    Drug resistance is a growing problem in modern medicine. The issue of drug resistance encompasses resistance of bacteria, viruses, parasites and other organisms to antibacterial agents and other drug treatments. This article examines the emergence of multidrug resistant pathogens and introduces a few of the methods available to address the issue – including some new […]

    Read More »

  • July 3, 2012

  • A Peak at PODD 2011

    A Presentation on Practical Guidance to Conveying the Value in your Drug Delivery. This Presentation was delivered by Fernando Salles, PhD, CLP, of Merck & Co. Inc. during the 2011 PODD program. For the 2012 program agenda, please click here.

    Read More »

  • July 3, 2012

  • Keynotes & Leadership Announced for Global Clinical Trials 3rd Annual Event

    New York – The Conference Forum has announced that the 3rd Annual Executing Global Clinical Trial’s event will take place on September 13-14 at the Fairmont Copley Square Hotel in Boston, MA.  “The trend to globalization creates opportunities and challenges for clinical trial management.  To be successful, we must focus on quality, ethics, fair market value, […]

    Read More »

  • July 2, 2012

  • A Peak at GCT 2011

    A Presentation on Corporate Social Responsibility, Applied Research Networks & Clinical Research Enterprise. This Presentation was delivered by Linda Strause, PhD of Vical Inc. and Matt Whalen, PhD of Impact LLC. during the 2011 GCT program. For the 2012 program agenda, please visit here.

    Read More »

  • June 4, 2012

  • A Peak at DPharm 2011: Private Public Partnerships Model: The Parkinson’s Progression Markers Initiative (PPMI): The Development of a Public-Private Partnership to Tackle Critical Research Hurdles This Presentation was delivered by Sohini Chowdhury, VP of Research Partnerships for the Michael J. Fox Foundation for Parkinsons Research during the 2011 DPharm program. For the 2012 program […]

    Read More »

  • June 1, 2012

  • New Speaker & Agenda Announcements

    We have added two exciting new items to our upcoming 3rd Annual Executing Global Clinical Trials event 2012! How to Do Clinical Trials in Europe: Clarifying Confusion, Changes & Updates An update on the clinical trial approval process in Europe How to get the correct scientific advice David R. Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare […]

    Read More »

  • May 23, 2012

  • Yo Adrian! – The Disruptive Innovation Event Was A Knockout

    Life Science Leaders Chief Editor, Rob Wright, was an attendee at DPharm 2011. Here are this thoughts on the conference. Philadelphia has a history of being the place where dreams become reality. Home to the signing of the U.S. Declaration of Independence and fictional boxing legend Rocky Balboa, Philly can now lay claim to yet […]

    Read More »

  • May 23, 2012

  • DPharm 2011 Co Chair Blog

    DPharm 2011 Co Chair Blog Our Co-Chair, Puneet Sapra, Director, World Wide Business Development & Innovation at Pfizer writes a blog about his thoughts from our September 2011 program: Last year, I had the pleasure of working with a distinguished and experienced team to curate the DPharm conference in Philadelphia in September — a TED-style […]

    Read More »

  • May 1, 2012

  • 2012 Dates Announced!

    2nd Annual PODD- Partnership Opportunities in Drug Delivery October 1-2, 2012 Boston Park Plaza Hotel,Boston, MA For more information click here.

    Read More »

  • May 1, 2012

  • PODD 2011 Pictures

    Pictures from our PODD 2011 Event, Omni Parker House Hotel, Boston, MA. For more information on our upcoming 2012 event, click here. Or join our LinkedIN group here. Click here to view these pictures larger

    Read More »

  • May 1, 2012

  • GCT 2011 Photos

    Click here to view these pictures larger Pictures from our 2011 Executing Global Clinical Trials event, Philadelphia Loews Hotel. Philadelphia, PA. For more information on our 2012 event click here. Or to join our Linked IN group click here.

    Read More »

  • April 20, 2012

  • 2012 Dates Announced!

    3rd Annual Executing Global Clinical Trials Conference September 13-14, 2012 Fairmont Copley Square Hotel, Boston, MA For more information click here.

    Read More »

  • March 29, 2012

  • 2012 & 2013 Dates Announced!

    2nd Annual Disruptive Innovations to Advance Clinical Trials for Pharma, Biologics & Devices September 13th & 14th 2012 Fairmont Copley Plaza, Boston, MA 3rd Annual Executing Global Clinical Trials September 13th & 14th 2012 Fairmont Copley Plaza, Boston, MA 2nd Annual PODD; Partnership Opportunities in Drug Delivery October 1st & 2nd 2012 Boston Park Plaza […]

    Read More »

  • March 27, 2012

  • R&D Leadership Summit 2012

    The Times Are A Changin’ In Drug Development R&D March 27, 2012 By Rob Wright, Chief Editor, Life Science Leader magazine This year’s R&D Leadership Summit took place March 19 to 20 in Aventura, FL. Organized by The Conference Forum and sponsored by RPS, the focus was on driving innovation, change, and performance of drug […]

    Read More »

  • March 1, 2012

  • New Paradigms to Fund and Move Drug Development 2012

    The New Paradigms to Fund and Advance Drug Development was held in January 10-12, 2012. Attended by all levels of Biotech CEOs, R&D leaders and the Investment community, the conference delivered information on alternative sources of funding, non-traditional partnering strategies and innovative approaches to drug approval for the successful commercialization of new therapies. For more […]

    Read More »

  • February 1, 2012

  • Partnership Opportunities in Drug Delivery 2011 slideshow

    The Conference Forum presented PODD, Partnership Opportunities in Drug Delivery, in October 2011 in Boston, MA. PODD was designed with two purposes: 1. To present a strategic level event for pharma and biotech business development and external licensing professionals with a thorough overview of the latest drug delivery technologies available along with an update on […]

    Read More »

  • January 31, 2012

  • DPharm 2011 Co Chair Blog

    Our Co-Chair, Puneet Sapra, Director, World Wide Business Development & Innovation at Pfizer writes a blog about his thoughts from our September 2011 program: Last year, I had the pleasure of working with a distinguished and experienced team to curate the DPharm conference in Philadelphia in September — a TED-style event showcasing innovations and leading […]

    Read More »